Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #5995613

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	1 610,1 SEK	204,000,000 SEK	—	—	248,000,000 SEK	—	2 057,7 SEK	4,929,000,000 SEK	—	5,456,000,000 SEK	—	1 266,5 SEK	167,000,000 SEK	—	—	154,000,000 SEK	—	1 780,0 SEK	5,062,000,000 SEK	61,000,000 SEK	9,396,000,000 SEK	113,000,000 SEK	1 428,4 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	3,436,000,000 SEK	—	—	—	—	3,269,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	—	—	—	—	—	1,000,000 SEK	—	—	—	—	1,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	- SEK	- SEK	—	—	3,435,000,000 SEK	3,435,000,000 SEK	—	- SEK	—	—	3,270,000,000 SEK	—	- SEK	—	—	3,270,000,000 SEK	- SEK	—	- SEK	—	—	—	—	—	—
Issue of equity	- SEK	50,000,000 SEK	—	—	- SEK	3,015,000,000 SEK	—	2,965,000,000 SEK	—	—	3,819,000,000 SEK	—	- SEK	—	—	- SEK	41,000,000 SEK	—	3,778,000,000 SEK	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	62,000,000 SEK	- SEK	—	—	- SEK	62,000,000 SEK	—	- SEK	—	—	72,000,000 SEK	—	72,000,000 SEK	—	—	- SEK	- SEK	—	- SEK	—	—	—	—	—	—